CA
NZ
UK
AU
IND
US
● The move reflected volatile trading typical of a thinly followed microcap.
● No new company news accompanied the rise.
● Shares climbed ahead of a scheduled poster presentation at a medical meeting.
● The drop extended a pullback after the stock climbed about 14% over the prior month.
● No fresh company news accompanied the climb.
● The company raised its 2026 adjusted earnings guidance by $0.40 per share.
● No fresh company announcement accompanied the surge.
● No same-day announcement accompanied the gain.
● No fresh company announcement accompanied the jump.
● The rebound came days after a kidney-transplant data presentation.
Please wait processing your request...